Author: itembalabantu
-
NHS-Galleri’s Primary Endpoint Was Negative. A Day Later, FDA’s Panel Voted Yes. They Were Answering Different Questions, About Different Devices
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. This post covers a peer-reviewed randomized trial and a public regulatory advisory-committee record for a listed company’s screening test. Every number below is attributed to its source tier — peer-reviewed abstract, FDA public…
-
Continuous Atom Reloading in Neutral-Atom Qubits: A Subsystem Result, Not Yet a Fault-Tolerant One
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. This post covers a peer-reviewed physics paper describing one subsystem of a neutral-atom quantum computer: how quickly a lost or used-up atomic qubit can be replaced from a reservoir without disturbing the qubits…
-
SHAKED in the ER: Accuracy Held, Adoption Fell
30-second summary What — In a single hospital in Haifa, Israel, researchers ran a 4-week, non-randomized, prospective quasi-experiment (n = 1,138 emergency department patients, propensity-score/IPTW-adjusted comparison across two parallel ED wings) of SHAKED, a multi-LLM clinical decision-support tool built on AWS Bedrock. The study is reported under the DECIDE-AI stage-1 standard — an early feasibility-and-safety…
-
A $16K Humanoid Completed a Gallbladder Removal in a Pig — But a Human Drove Every Move
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. The 30-second version What. A UC San Diego team (Yip lab) mounted wristed laparoscopic instruments on a low-cost commercial humanoid (Unitree G1) and ran a three-stage study — benchtop characterization, dry-lab user study,…
